drugset / Trial / NCT02299557

The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients

NCT02299557

Phase 1/2 Completed 19 enrolled RDD Pharma Ltd
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is an double blinded, cross-over study to determine the effect of Oxymetazoline gel on anal resting pressure and fecal incontinence in patients with spinal cord injury. Approximately 17 subjects are expected to complete this 10 weeks study that will include two treatment periods of 4 weeks each, and one 2 weeks wash out period.

Timeline

Start
2014-11
Primary completion
2015-06
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxymetazoline Other / unclassified Other

Indications